Harel Insurance Investments & Financial Services Ltd. Astrazeneca PLC Transaction History
Harel Insurance Investments & Financial Services Ltd.
- $7.64 Billion
- Q1 2025
A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 6,350 shares of AZN stock, worth $447,103. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,350
Previous 5,527
14.89%
Holding current value
$447,103
Previous $362,000
29.01%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.02 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.86 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.24 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.2 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $218B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...